ALEXIS FASONE: Open Payments
NPI 1861116451 · BELLEAIR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 16 payments from 9 companies in 2025. Trend: 2023 $946 · 2024 $1,322 · 2025 $756
Food & beverage: $676Education: $80
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $132 |
| Botanix SB Inc | 1 | $128 |
| Galderma Laboratories, L.P. | 3 | $108 |
| Journey Medical Corporation | 2 | $103 |
| GENZYME CORPORATION | 2 | $92 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Janssen Biotech, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $15 |
Products named: DUPIXENT, SOFDRA, NEMLUVIO, TREMFYA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
